共 26 条
[1]
Stewart W.C., Ritch R., Shin D.H., The efficacy of apraclonidine as an adjunct to timolol therapy, Arch Ophthalmol, 113, pp. 287-292, (1995)
[2]
Colemann A.L., Robin A.L., Pollack I.P., Apraclonidine hydrochloride, Ophthalmol Clin North Am, 2, pp. 97-108, (1989)
[3]
Abrams D.A., Robin A.L., Pollack I.P., deFaller J.M., DeSantis L., The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers, Arch Ophthalmol, 105, pp. 1205-1207, (1987)
[4]
Coleman A.L., Robin A.L., Pollack I.P., Rudikoff M.T., Enger C., Mayer P.R., Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine hydrochloride, Arch Ophthalmol, 108, pp. 1264-1267, (1990)
[5]
Robin A.L., Pollack I.P., deFaller J.M., Effects of topical ALO 2145 (p-aminoclonidine hydrochloride, aplonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy, Arch Ophthalmol, 106, pp. 308-309, (1988)
[6]
Robin A.L., Pollack I.P., Enger L., House B., Medical therapy for the acute postoperative intraocular pressure rise following argon laser trabeculoplasty, Arch Ophthalmol, 105, pp. 1476-1477, (1987)
[7]
Pollack I.P., Brown R.H., Crandell A.S., Robin A.L., Stewart R.H., White G.L., Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine, Arch Ophthalmol, 106, pp. 754-757, (1988)
[8]
Robin A.L., The role of apraclonidine hydrochloride in laser therapy for glaucoma, Trans Am Ophthalmol Soc, 87, pp. 729-761, (1989)
[9]
Kitazawa Y., Taniguchi T., Sugiyama K., Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy, Ophthalmic Surg, 20, pp. 49-52, (1989)
[10]
Robin A.L., Apraclonidine uses, Arch Ophthalmol, 108, (1990)